John N. Spencer Jr.

This profile gathers the share dealings of John N. Spencer Jr. across 3 companies, led by ClearPoint Neuro, Inc., GeoVax Labs, Inc. and Textmunication Holdings, Inc. We count 52 filings; the first trade dates from 7 June 2006 and the latest from 17 October 2025.

The open-market record is one-sided, with 15 purchases worth €177k and not one sale. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 34 share grants. In 2025 alone, the filings show 2 purchases and no sales.

A typical purchase (the median) is worth €6,191. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 17% of cases; the median change was -26.9%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 20 October 2025, reports an open-market purchase of €4,699 in GeoVax Labs, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.